AstraZeneca

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed.

CEO

Pascal Soriot

CEOPascal Soriot

Employees

94,300

Employees94,300

Headquarters

Cambridge, Cambridgeshire

HeadquartersCambridge, Cambridgeshire

Founded

1913

Founded1913

Employees

94,300

Employees94,300

AZN Key Statistics

Market cap

265.45B

Market cap265.45B

Price-Earnings ratio

31.68

Price-Earnings ratio31.68

Dividend yield

1.81%

Dividend yield1.81%

Average volume

6.95M

Average volume6.95M

High today

$86.38

High today$86.38

Low today

$84.99

Low today$84.99

Open price

$85.89

Open price$85.89

Volume

9.09M

Volume9.09M

52 Week high

$86.57

52 Week high$86.57

52 Week low

$61.24

52 Week low$61.24

AZN News

Nasdaq 6h

AstraZeneca To Invest $4.5 Bln In Virginia Facility, Create 3,600 Jobs

(RTTNews) - AstraZeneca Plc. (AZN, AZN.L, ZEG.DE,AZN.ST) announced a $4.5 billion investment in a new advanced manufacturing facility at Rivanna Futures in Albe...

Benzinga 14h

AstraZeneca Expands Virginia Investment To $4.5 Billion For Cancer, Obesity Drugs

AstraZeneca Plc (NASDAQ:AZN) on Thursday said it will invest $4.5 billion in its new manufacturing facility in Virginia, a proposed increase of $500 million to...

Nasdaq 16h

Turbine Partners With AstraZeneca To Accelerate AI-Driven ADC Discovery

(RTTNews) - AstraZeneca (AZN), Thursday announced a collaboration with Turbine, a biotechnology company specializing in AI-powered virtual biological experiment...

Analyst ratings

81%

of 31 ratings

Buy

80.6%

Hold

19.4%

Sell

More AZN News

TipRanks 17h

AstraZeneca to invest $4.5B in new manufacturing facility in Virginia

AstraZeneca (AZN) announced that it will invest $4.5B in its new manufacturing facility in Virginia, a proposed increase of $500M to support the enhanced manufa...

TipRanks 17h

AstraZeneca’s ATHENA Study: A New Chapter in Severe Asthma Treatment

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock...

TipRanks 23h

AstraZeneca announces collaboration with Turbine

Turbine announced a collaboration with AstraZeneca (AZN) to test the ability of Turbine’s platform to rationalize antibody-drug conjugate discovery by predictin...

TipRanks 2d

AstraZeneca’s CKD Study in Brazil: Key Insights and Market Impact

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock...

TipRanks 3d

AstraZeneca’s AZD4144: Promising Obesity Treatment Under Study

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock...

Benzinga 3d

AstraZeneca's Baxdrostat Shows Meaningful Blood Pressure Control In Patients With Resistant Hypertension

On Tuesday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the Bax24 Phase 3 trial to evaluate the safety, tolerability, and the effect of 2mg ba...

Investor's Business Daily 3d

Best Stocks To Watch: Two New IPOs, Pharma Titan AstraZeneca And Electrical Grid Play Emcor Trade Near Buy Points

Stocks Near A Buy Zone Best Stocks To Watch: Two New IPOs, Pharma Titan AstraZeneca And Electrical Grid Play Emcor Trade Near Buy Points Licensing The IPO secto...